BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

15.72
Delayed Data
As of Jul 28
 +0.66 / +4.38%
Today’s Change
7.85
Today|||52-Week Range
16.83
+29.28%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close15.06
Today’s open15.19
Day’s range14.98 - 15.79
Volume451,622
Average volume (3 months)910,661
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 07/28/2015

Growth & Valuation

Earnings growth (last year)-23.64%
Earnings growth (this year)-50.74%
Earnings growth (next 5 years)-22.83%
Revenue growth (last year)-21.48%
P/E ratioNM
Price/Sales59.67
Price/Book14.33

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc+1.18+3.70%
ADAPAdaptimmune Therapeu...+0.49+3.31%
FMIFoundation Medicine ...-0.45-1.48%
MCRBSeres Therapeutics I...+1.37+3.91%
Data as of 3:59pm ET, 07/28/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$13.6M
Annual profit (last year)-$45.2M
Net profit margin-332.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Chief Financial Officer, Treasurer, CAO &
SVP
Thomas R. Staab
Corporate headquarters
Birmingham, Alabama

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers